A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CB06-036 in Subjects With Chronic Hepatitis B

计划入组 30 人 · 首次发布于 2023 年 4 月 25 日

Safety Study of Single Oral Doses of VBY-036 in Healthy Volunteers (VBY036P1A)

计划入组 48 人 · 首次发布于 2013 年 7 月 30 日

A Bridging Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB06-036 in Healthy Subjects in China

计划入组 12 人 · 首次发布于 2023 年 10 月 26 日

QF-036

IMG-036

SY-036

PhotonPharma, Inc.

United States

HLB Cell Co., Ltd.

South Korea

Acufocus, Inc.

United States

Vicero Appoints Dr. Han Myint as Chief Medical Officer to Advance VINCOBODY Immunotherapy Pipeline

Power Metals Achieves High-Grade Cesium Concentrate at Case Lake Project

MSD Pharma Receives Conditional Approval for Phase III Trial of Sacituzumab Tirumotecan in India